VOYA Investment Management
OCUL icon

VOYA Investment Management’s Ocular Therapeutix OCUL Stock Holding History

VOYA Investment Management’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$897K Buy
91,375
+7,711
+9% +$69.9K ﹤0.01% 1550
2026
Q1 		$709K Sell
83,664
-18,590
-18% -$177K ﹤0.01% 1590
2025
Q4 		$1.24M Sell
102,254
-82,173
-45% -$998K ﹤0.01% 1405
2025
Q3 		$2.16M Sell
184,427
-107,143
-37% -$1.28M ﹤0.01% 1204
2025
Q2 		$2.71M Sell
291,570
-44,946
-13% -$352K ﹤0.01% 1176
2025
Q1 		$2.47M Sell
336,516
-34,719
-9% -$267K ﹤0.01% 1219
2024
Q4 		$3.17M Buy
371,235
+97,602
+36% +$952K ﹤0.01% 1122
2024
Q3 		$2.38M Buy
273,633
+185,582
+211% +$1.53M ﹤0.01% 1282
2024
Q2 		$602K Buy
88,051
+51,095
+138% +$315K ﹤0.01% 1896
2024
Q1 		$336K Buy
36,956
+4,706
+15% +$33.4K ﹤0.01% 2193
2023
Q4 		$144K Hold
32,250
– – ﹤0.01% 2669
2023
Q3 		$101K Buy
32,250
+1,337
+4% +$5.47K ﹤0.01% 2729
2023
Q2 		$160K Buy
30,913
+983
+3% +$5.85K ﹤0.01% 2661
2023
Q1 		$158K Hold
29,930
– – ﹤0.01% 2604
2022
Q4 		$84.1K Hold
29,930
– – ﹤0.01% 2782
2022
Q3 		$124K Hold
29,930
– – ﹤0.01% 2732
2022
Q2 		$120K Hold
29,930
– – ﹤0.01% 2569
2022
Q1 		$148K Hold
29,930
– – ﹤0.01% 2435
2021
Q4 		$209K Buy
29,930
+76
+0.3% +$590 ﹤0.01% 2486
2021
Q3 		$299K Hold
29,854
– – ﹤0.01% 2351
2021
Q2 		$423K Sell
29,854
-1,764
-6% -$26.8K ﹤0.01% 2188
2021
Q1 		$519K Buy
31,618
+2,418
+8% +$46.6K ﹤0.01% 2012
2020
Q4 		$604K Buy
29,200
+9,025
+45% +$134K ﹤0.01% 1794
2020
Q3 		$154K Buy
20,175
+1,883
+10% +$15.6K ﹤0.01% 2239
2020
Q2 		$152K Sell
18,292
-2,901
-14% -$19.2K ﹤0.01% 2249
2020
Q1 		$105K Sell
21,193
-1,368
-6% -$6.75K ﹤0.01% 2328
2019
Q4 		$89K Buy
22,561
+5,277
+31% +$18.3K ﹤0.01% 2573
2019
Q3 		$53K Hold
17,284
– – ﹤0.01% 2497
2019
Q2 		$76K Buy
17,284
+3,128
+22% +$11.6K ﹤0.01% 2509
2019
Q1 		$56K Hold
14,156
– – ﹤0.01% 2500
2018
Q4 		$56K Hold
14,156
– – ﹤0.01% 2477
2018
Q3 		$97K Hold
14,156
– – ﹤0.01% 2506
2018
Q2 		$96K Buy
14,156
+3,177
+29% +$21.8K ﹤0.01% 2527
2018
Q1 		$71K Hold
10,979
– – ﹤0.01% 2519
2017
Q4 		$49K Hold
10,979
– – ﹤0.01% 2571
2017
Q3 		$68K Hold
10,979
– – ﹤0.01% 2606
2017
Q2 		$102K Buy
+10,979
New +$106K ﹤0.01% 2566
2016
Q4 		– Sell
-10,866
Closed -$75K – 2534
2016
Q3 		$75K Hold
10,866
– – ﹤0.01% 2502
2016
Q2 		$54K Buy
+10,866
New +$108K ﹤0.01% 2542

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VOYA Investment Management's OCUL Position: Q2 2026 in Review

VOYA Investment Management increased its Ocular Therapeutix (OCUL) stake by 9.2% in Q2 2026, buying an estimated $69.9K and bringing the position to 91,375 shares worth $897K. The position accounts for ﹤0.01% of the portfolio, ranked #1550.

VOYA Investment Management first reported a position in OCUL in Q2 2016 and has held it in 39 quarters since. The position peaked at $3.17M in Q4 2024. 261 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

  • VOYA Investment Management held 91,375 shares of Ocular Therapeutix worth $897K as of Q2 2026.
  • VOYA Investment Management bought 7,711 Ocular Therapeutix shares in Q2 2026, an estimated $69.9K.
  • Ocular Therapeutix made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #1550 holding.
  • VOYA Investment Management first reported a position in Ocular Therapeutix in Q2 2016 and has held it in 39 quarters since.
  • VOYA Investment Management's Ocular Therapeutix position peaked at $3.17M in Q4 2024.
  • 261 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.